1 st JAMAICAN PAEDIATRIC NEPHROLOGY CONFERENCE Jamaica Conference Centre Kingston Jamaica October 4 th 2014 in association with
1st JAMAICAN PAEDIATRIC NEPHROLOGY CONFERENCE
Jamaica Conference Centre
Kingston Jamaica October 4th 2014
in association with
Antenatal Hydronephrosis-‐ When To Act
Rulan S. Parekh Professor of Pediatrics and Medicine
Hospital for Sick Children University of Toronto
Learning Objec<ves
At the end of this session you will be able to:
1. Understand the significance of antenatal hydronephrosis (ANH)
2. Understand the management of a newborn with ANH
3. Understand some management issues of newborns with ANH
Outline
• Antenatal Hydronephrosis • DefiniKons • Measurement • Epidemiology
• Postnatal Hydronephrosis • DefiniKons • Measurement • Epidemiology • EKology • Management
• Future Risk
Congenital Anomalies of the Kidney and Urinary Tract -‐ CAKUT Broad range of anomalies • MalformaKons of the renal parenchyma • AbnormaliKes of embryonic migraKon • AbnormaliKes of the developing urinary collecKon system
– Vesicoureteral reflux (VUR) – Ureteropelvic juncKon obstrucKon (UPJO) – Ureterovesical juncKon obstrucKon (UVJO) – Posterior urethral valves (PUVs) – Prune Belly syndrome (males) – Ureterocele
Variables involved in urine flow impairment
Geary and Schaefer (eds.), Comprehensive Pediatric Nephrology, Chapter 37
Consequence of congenital urethral obstruction
Geary and Schaefer (eds.), Comprehensive Pediatric Nephrology, Chapter 37
Antenatal hydronephrosis • DefiniKons by ultrasound:
– Society of Fetal Urology (SFU) based on • Pelvic dilataKon • Number of calyces seen • Presence and severity of parenchymal atrophy
– Maximum renal pelvic diameter measured from the anterioposterior diameter of the renal pelvis
• Mild > 4-‐10 mm • Moderate >10 mm • Severe or at greatest risk >15 mm
– AddiKonal factors • Unilateral or bilateral • Size of kidneys/parenchymal • Bladder abnormaliKes • AmnioKc fluid • Other issues-‐ ? Down syndrome or other chromosomal anomalies
Timing of antenatal ultrasound
• 12-‐15th week of gestaKon: Fetal hydronephrosis (kidney/bladder) can be detected
• 16-‐20th week of gestaKon: OpKmal Kme window for screening ultrasound (before 18-‐24th week may fail detecKng significant disease)
• 28-‐34th week of gestaKon (third trimester): Repeat US to idenKfy fetuses requiring postnatal intervenKon
Antenatal hydronephrosis (ANH) • Epidemiology:
– Incidence • ProspecKve studies >4-‐5 mm in 2nd trimester
– 0.6-‐4.5% in over 25,000 women in Europe
• Meta-‐analyses of 17 studies and various definiKons – 1.6% in over 100,000 women
– Majority are transient over 65% – More common among males – Antenatal hydro severity predicts postnatal degree of hydronephrosis BUT risk of vesicoureteral reflux varies (measurement error?)
Degree of antenatal hydronephrosis
Hydronephrosis ANH CAKUT
Mild < 7 mm (2nd) < 9 mm (3rd) 12%
Moderate 7-‐10 mm (2nd) 9-‐15 mm (3rd) 45%
Severe > 10 mm (2nd) > 15 mm (3rd) 88%
Lee et al, Pediatrics 2006
Congenital Anomalies of the Kidney and Urinary Tract -‐ CAKUT Broad range of anomalies • Malformations of the renal parenchyma • Abnormalities of embryonic migration • Abnormalities of the developing urinary collection system
– Vesicoureteral reflux (VUR) – Ureteropelvic junction obstruction (UPJO) – Ureterovesical junction obstruction (UVJO) – Posterior urethral valves (PUVs)
Prune Belly syndrome (males) – Ureterocele
Outcome of antenatal hydronephrosis
• Transient/physiologic 63% • Uteropelvic juncKon obstrucKon 11% • Vesicoureteral reflux 9% • Megaureter 4% • Ureterocele 2% • Posterior Urethral valves 1% • Others 10%
Vesicoureteral reflux (VUR)
Geary and Schaefer (eds.), Comprehensive Pediatric Nephrology, Chapter 37
Obstruc<ons of upper urinary tract
1. Upper calyx syndrome 2. Ureteropelvic juncKon obstrucKon (UPJO) 3. Ureterovesical juncKon obstrucKon (UVJO) 4. Ureterocele
Management of antenatal hydronephrosis • Ultrasound aier 48 hours of life
– PotenKally volume depleted – Increasing renal flow in first 48 hours of life – Thus, increasing glomerular filtraKon and increased urine output
• Prior to 48 hours of life – If concern of significant renal impairment
• Renal parenchymal disease • Bilateral • Bladder involvement • Other congenital anomalies
– If negaKve, cannot rule out persistent hydronephrosis
Antenatal Hydronephrosis: Current Protocol at Sick Kids
• All children with prior history of ANH are referred for ultrasound – Most visits occur within 1-‐2 months aier birth – Most on anKbioKc prophylaxis – Detailed physical exam to rule out syndromic disease – Normal, low risk or high risk
• High risk: If postnatal ultrasound renal pelvis diameter >12 mm or caliectasis or another renal, bladder or urinary tract anomaly
– Voiding cystourethrogram (VCUG) to rule out VUR – Simultaneously MAG-‐3 scan ( or when VCUG is normal) to rule out UPJ – Remain on anKbioKc prophylaxis
• Low risk: If postnatal ultrasound renal pelvis diameter 7-‐12 mm – Followed at 3-‐12 months with US depending on the degree of AP diameter – AnKbioKc prophylaxis for at least 2-‐3 months and longer depends on follow-‐up – Follow-‐up ultrasound and DMSA to evaluate for potenKal renal scarring
• Children with UTI will undergo VCUG and DMSA irrespecKve of US
Why not do a VCUG/MAG-‐3 in every child?
• VCUG – For a child 5-‐10 years old, the effecKve radiaKon dose
• 1.6 mSv • average person receives from natural background radiaKon in 6 months
– For an infant, the effecKve radiaKon dose • 0.8 mSv • average person receives from natural background radiaKon in 3 months
• MAG-‐3/DMSA – ~1mSv
Children's (Pediatric) Voiding Cystourethrogram Copyright© 2010, RadiologyInfo.org
Risk • CAKUT
– Familial – Can’t jusKfy screening asymptomaKc family members
• Urinary tract infecKons(UTIs) – Females – DysfuncKonal voiding
• Progression – Scarring can be independent of UTIs and prophylaxis – Scarring is common cause of hypertension in adolescents
– Slower rate of progression to chronic kidney disease compared to renal parenchymal disorders
Gene<c loci and CAKUT/ VUR
• Familial based studies – Genome wide linkage analyses – Among Ashkenazi families, recessive locus on 12p11-‐q13 – Among a Somalian family, recessive locus on 8q24 – Among European Americans, SNPs idenKfied at mulKple loci – Among Europeans, 3 SNPs idenKfied in one group but not validated in a separate group
• No case-‐control genome wide associaKon study • Issues
– Sample size – Phenotypic variability-‐ extreme phenotypes/syndromes – Long-‐term outcome is mild in the majority of VUR
Discussions with Families
• Provide informaKon on – Hydronephrosis – IndicaKons for severity of disease – Ask about family history – Discuss need for careful monitoring and follow-‐up – Guarded about making comments on prognosis – Provide all expectant families with reading material on tests and anKbioKcs
Summary • Antenatal hydronephrosis occurs in <5% of pregnancies
• Over 65% will have no long-‐term sequelae • Postnatal ultrasound should be done aier 48 hours of life
• Family history is important risk factor • Overall long-‐term outcome is very good • AnKbioKc prophylaxis is currently recommended for even mild disease
• Management depends iniKal findings (pracKce is evolving)
Reviews • Sidhu, G, Beyene, J, Rosenblum, ND. Outcome of isolated antenatal hydronephrosis: a systemaKc review and meta-‐analysis. Pediatr Nephrol 2006; 21:218.
• Lee RS; Cendron M; Kinnamon DD; Nguyen HT, Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-‐analysis. Pediatrics. 2006 Aug;118(2):586-‐93.
• Woodward, M, Frank, D. Postnatal management of antenatal hydronephrosis. BJU Int 2002; 89:149.